Cost‐effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion
Respirology2016Vol. 22(4), pp. 764–770
Citations Over TimeTop 10% of 2016 papers
Jordan Olfert, Erika Penz, Braden Manns, Eleanor Mishra, Helen Davies, Robert F. Miller, Ramón Luengo-Fernández, Song Gao, Najib M. Rahman
Abstract
IPC is cost-effective when compared with talc, although substantial uncertainty exists around this estimate. IPC appears most cost-effective in patients with limited survival. If significant nursing time is required for catheter drainage, IPC becomes less likely to be cost-effective. Either therapy may be considered as a first-line option in treating malignant pleural effusion in patients without history of prior pleurodesis, with consideration for patient survival, support and preferences.
Related Papers
- → Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions.(2015)52 cited
- → PLEURODESIS IN PATIENTS WITH MALIGNANT PLEURAL EFFUSIONS: EFFICACY OF DOXYCYCLINE(2006)3 cited
- → Quality of Life in Patients With Malignant Pleural Effusion Undergoing Pleurodesis(2012)1 cited
- → An Evaluation of treatment of malignant pleural effusion by pleurodesis(1979)
- → Pleurodesis with Bleomycin via small-bore catheter in treatment of malignant pleural effusion(2013)